SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marguerite Prior, Chandramouli Chiruta, Antonio Currais, Josh Goldberg, Justin Ramsey, Richard Dargusch, Pamela A. Maher, David Schubert, Back to the Future with Phenotypic Screening, ACS Chemical Neuroscience, 2014, 5, 7, 503

    CrossRef

  2. 2
    Giacomo Koch, Francesco Di Lorenzo, Sonia Bonnì, Viola Giacobbe, Marco Bozzali, Carlo Caltagirone, Alessandro Martorana, Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients, Neuropsychopharmacology, 2014,

    CrossRef

  3. 3
    Alison J Yarnall, What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition, Neurodegenerative Disease Management, 2014, 4, 2, 127

    CrossRef

  4. 4
    Brian S. Appleby, Dimitrios Nacopoulos, Nicholas Milano, Kate Zhong, Jeffrey L. Cummings, A Review: Treatment of Alzheimer’s Disease Discovered in Repurposed Agents, Dementia and Geriatric Cognitive Disorders, 2013, 35, 1-2, 1

    CrossRef

  5. 5
    Chun-Ming Wang, Ming-Yan Liu, Fang Wang, Min-Jie Wei, Shuang Wang, Chun-Fu Wu, Jing-Yu Yang, Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease, Pharmacology Biochemistry and Behavior, 2013, 106, 57

    CrossRef

  6. 6
    Ludwig Trillo, Devsmita Das, Wayne Hsieh, Brian Medina, Sarah Moghadam, Bill Lin, Van Dang, Martha Millan Sanchez, Zurine De Miguel, J. Wesson Ashford, Ahmad Salehi, Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care, Neuroscience & Biobehavioral Reviews, 2013, 37, 8, 1363

    CrossRef

  7. 7
    Alessandro Martorana, Francesco Di Lorenzo, Zaira Esposito, Temistocle Lo Giudice, Giorgio Bernardi, Carlo Caltagirone, Giacomo Koch, Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients, Neuropharmacology, 2013, 64, 108

    CrossRef

  8. 8
    Yunlong Li, Establishment of experimental models for Alzheimer's disease research, International Journal of Neuroscience, 2013, 123, 12, 823

    CrossRef

  9. 9
    Darakhshan Jabeen Haleem, Extending therapeutic use of psychostimulants: Focus on serotonin-1A receptor, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, 46, 170

    CrossRef

  10. 10
    Benoît Leclerc, Abedelnasser Abulrob, Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  11. 11
    Alessandro Stefani, Livia Brusa, Enrica Olivola, Mariangela Pierantozzi, Alessandro Martorana, CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD, Journal of Neural Transmission, 2012, 119, 7, 861

    CrossRef

  12. 12
    Kazuma Murakami, Takahiko Shimizu, Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease, Communicative & Integrative Biology, 2012, 5, 3, 255

    CrossRef

  13. 13
    Federico Benetti, Stefano Gustincich, Giuseppe Legname, Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits, Expert Opinion on Drug Discovery, 2012, 7, 3, 245

    CrossRef

  14. 14
    Kim Wilkinson, Joseph El Khoury, Microglial Scavenger Receptors and Their Roles in the Pathogenesis of Alzheimer's Disease, International Journal of Alzheimer's Disease, 2012, 2012, 1

    CrossRef

  15. 15
    Mikio Shoji, Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer’s Disease: Clinical Molecular and Genetic Studies on Alzheimer’s Disease, Journal of Pharmacological Sciences, 2012, 118, 3, 345

    CrossRef

  16. 16
    Yun-Lian Lin, Huey-Jen Tsay, Yung-Feng Liao, Mine-Fong Wu, Chuen-Neu Wang, Young-Ji Shiao, The Components ofFlemingia macrophyllaAttenuate Amyloidβ-Protein Accumulation by Regulating Amyloidβ-Protein Metabolic Pathway, Evidence-Based Complementary and Alternative Medicine, 2012, 2012, 1

    CrossRef

  17. 17
    Naotaka Izuo, Toshiaki Kume, Mizuho Sato, Kazuma Murakami, Kazuhiro Irie, Yasuhiko Izumi, Akinori Akaike, Toxicity in Rat Primary Neurons through the Cellular Oxidative Stress Induced by the Turn Formation at Positions 22 and 23 of Aβ42, ACS Chemical Neuroscience, 2012, 3, 9, 674

    CrossRef

  18. 18
    Yasumasa Ohyagi, A drug targeting intracellular amyloid-β and oxidative stress: Apomorphine, Rinsho Shinkeigaku, 2011, 51, 11, 884

    CrossRef

  19. 19
    Zsolt Radak, Zhongfu Zhao, Sataro Goto, Erika Koltai, Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA, Molecular Aspects of Medicine, 2011, 32, 4-6, 305

    CrossRef

  20. 20
    Takeshi Tabira, Alzheimer’s disease vaccines: promises and pitfalls, Clinical Investigation, 2011, 1, 7, 969

    CrossRef

  21. 21
    John W. Steele, Sam Gandy, Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?, Annals of Neurology, 2011, 69, 2